RT Journal Article
SR Electronic
T1 Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002752
DO 10.1136/jitc-2021-002752
VO 9
IS 8
A1 Kyi, Chrisann
A1 Doubrovina, Ekaterina
A1 Zhou, Qin
A1 Kravetz, Sara
A1 Iasonos, Alexia
A1 Aghajanian, Carol
A1 Sabbatini, Paul
A1 Spriggs, David
A1 O'Reilly, Richard J
A1 O’Cearbhaill, Roisin E
YR 2021
UL http://jitc.bmj.com/content/9/8/e002752.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.